glp-1 versus glp-2 glp 1 or glp 2 Discovery, characterization, and clinical development of the glucagon-like peptides vs vs GLP-3: – glp-1 vs glp-2 vs glp-3

A novel dual GIPGLP1 receptor agonist, tirzepatide, is currently under development for the treatment of type 2 diabetes mellitus (T2DM)

2020;105(3):dgz175

72 weeks High-Dose Semaglutide (7.2 mg weekly, injectable) Semaglutide 7.2 mg: 18.8% Semaglutide 2.4 mg: 15.8% Placebo: 3.5% n 1,400

This RKMD product is slightly better as it does not involve the direct absorption of glutathione, but instead uses other compounds known to increase glutathione production and availability within the body naturally

As with any wellness intervention, it works best as part of a comprehensive program that includes healthy nutrition and regular physical activity